Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
By Bryan Mena, CNN Washington, DC (CNN) — The US economy is set to reap considerable benefits from Americans taking popular medications used for weight loss, including Ozempic and Wegovy, Goldman Sachs analysts wrote in a recent research report. Those drugs are part of a powerful new class of medications that has taken the world
Continue Reading